Stage4Hope is proud to announce a $2.5 million multi-year research commitment to Memorial Sloan Kettering Cancer Center (MSK), one of the world’s premier cancer research and treatment institutions. This commitment will help accelerate groundbreaking research to expand treatment options and precision therapies, offering new hope to patients with advanced-stage cancers.
The funding will support translational cancer research led by Alexander Drilon, MD, Chief of the Early Drug Development Service at MSK and a leading investigator in precision oncology. Dr. Drilon’s work focuses on translating scientific discoveries into targeted therapies and advancing them through early-phase clinical trials for patients with cancers driven by specific genetic alterations.
“Support for translational research allows us to move discoveries from the laboratory into clinical trials where they can begin helping patients. We are grateful for Stage4Hope’s commitment to advancing this work and expanding the possibilities for people facing cancers driven by targetable genetic alterations,” said Dr. Drilon.
Since the beginning, Stage4Hope has been building partnerships with premier cancer institutions while expanding programs designed to remove barriers to accessing life-saving care. “This commitment reflects the mission at the heart of Stage4Hope,” Stage4Hope Founder Stacy Carter said. “We are working to accelerate access to the most advanced cancer care in the world, support the research that will shape the future of treatment, and walk alongside patients and families as they navigate one of the most difficult journeys of their lives.”
Through partnerships with leading cancer institutions like MSK, Stage4Hope works to accelerate patient access to specialized cancer care and clinical trials, helping individuals connect quickly with expert physicians and advanced treatment programs. We also provide travel assistance grants for patients who must travel to receive specialized care at premier cancer centers.
Access the full media release here >
To learn more about Stage4Hope’s partnership with Memorial Sloan Kettering Cancer Center, and how to support this work, visit: stage4hope.org/accelerating-access-to-life-saving-cancer-care.
